The antibacterial activity of epigallocatechin gallate (EGCg)
Introduction
It is well known that Japanese green tea has antibacterial activity against various foodborne pathogenic bacteria including Clostridium botulinum 1,2), Staphylococcus aureus3), Vibrio parahemolyticus3), Clostridium perfringens 3), and Bacillus cereus 3) , Salmonella typhi, Shigella dysenteriae, Campylobacter jejuni, and Vibrio cholerae4). In addition , there are reports that catechin is effective against infections due to Bordetella pertussis5), Mycoplasma pneumoniae6) , Trichophyton species7), rotavirus, enterovirus8 , and influenza virus9) . Moreover, the catechin in tea extract inhibits glucan synthesis by glucosyltransferase from Streptococcus mutans , thereby preventing dental caries10) Recently, Toda et al. showed that epigallocatechin gallate (EGCg) , one of the major classes of catechins, has antibacterial activity against methicillin-resistant S . aureus (MRSA)10). MRSA is a major nosocomial pathogen which causes problems worldwide . However, no clinical application of catechin in MRSA infection has yet been reported. The minimum inhibitory concentration (MIC) of catechin against MRSA likewise has not been determined. In order to determine the possible clinical usefulness of catechin in MRSA infections , we quantitatively measurd the activity of extracts of Japanese tea including EGCg against MRSA strains isolated in our university hospital. In addition, we examined the physical effects of conditions such as boiling and freezing, on catechin to decide on appropriate conditions for preservation of catechin for clinical use. Polyphenon-10 consists of 50% EGCg, the results seem to be reasonable.
2) The mechanism of action is killing of the bacteria at high concentrations, suggesting that EGCg has a concentration-dependent bactericidal activity. Toda et al. also showed that EGCg is bactericidal against MRSA14). 3) These compounds are highly stable under various physical conditions including freezing and boiling. In addition, they are preserved well even at room temperature. Thus, catechins are so well preserved that they appear to be candidates for clinical use. However, the MICs of catechin are so high, unlike those of antibiotics, that it may be difficult to achieve catechin tissue levels that are high enough following intestinal absorption after oral administration.
Catechins seem to be suitable for oral administration for the treatment of intestinal infections or colonization and for topical administration for the treatment of skin infections or colonization. Inhalation therapy with catechins could also be recommended for respiratory tract infections or colonization.
Catechins in solution can be well preserved in a refrigerator for up to a month. In addition, they are heastable, so that even hot water tea extracts (so-called tea drink), which contain antibacterial activity equivalent to 0.5-1.0 mg of polyphenon (data not shown), are also useful when catechin extract is not available, although the concentration does not appear to be high enough for clinical use.
In the future, we will investigate the mechanism of action of this EGCg against MRSA using in vitro and in vivo experiments. Furthermore, we may propose a clinical trial of this agent against MRSA infection and colonization.
